FDA Approves Lilly's Alimta (pemetrexed) for the Second-Line Treatment of Advanced Lung Cancer

INDIANAPOLIS - Today, Eli Lilly and Company's anti-cancer drug Alimta® (pronounced: "uh-LIMB-ta") received its second U.S. approval in 2004. The U.S. Food and Drug Administration granted accelerated approval for Alimta for the treatment of locally advanced or metastatic non-small cell lung cancer in previously treated patients. In February, Alimta was approved, in combination with cisplatin (a common chemotherapy agent), for the treatment of malignant pleural mesothelioma, a cancer often associated with asbestos exposure.

News Source: Lilly.com | Published: August 24, 2004 | Read Full Story

Contact an Asbestos and Mesothelioma Attorney, Lawyer, Law Firm

Please fill out the form below to contact an attorney. Provide as much information as possible to speed the processing of your inquiry (Only United States residents are eligible).

Contact Information
	*Are required items.
*First Name:
*Last Name:
Email Address:
*Daytime Phone:
Evening Phone:
*Zip Code:
Case Information
Have you, or the person you are contacting us on behalf of, been diagnosed with mesothelioma:
Yes: No:
Date of diagnosis:
*Comments: (Please describe your legal issues and needs.)
Terms
I understand submission of information submission of information for review does not create, is not intended to create, and must not be relied upon as creating, an attorney-client relationship. I understand such a relationship can only be created by the agreement of both the client and the attorney, evidenced by a written retainer agreement that has been signed by client and counter-signed by the attorney. By submitting your expression of interest you are consenting to receive telephone calls from participating law firms even if you are currently on the do-not-call list. *I Agree to these terms: